Misfolded amyloid-beta conformational variants (strains) as drivers of Alzheimer’s disease neuropathology

Misfolded amyloid-beta conformational variants (strains) as drivers of Alzheimer’s disease neuropathology

Saved in:

Bibliographic Details
Main Authors:	Salvatore Saieva, Rodrigo Morales
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-11-01
Series:	Neural Regeneration Research
Online Access:	https://journals.lww.com/10.4103/NRR.NRR-D-24-00699
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Intraneuronal binding of amyloid beta with reelin-Implications for the onset of Alzheimer's disease.
by: Asgeir Kobro-Flatmoen, et al.
Published: (2025-01-01)

An approach to predict and inhibit Amyloid Beta dimerization pattern in Alzheimer’s disease
by: Sreekanya Roy, et al.
Published: (2025-06-01)

Zinc Metalloproteinases and Amyloid Beta-Peptide Metabolism: The Positive Side of Proteolysis in Alzheimer's Disease
by: Mallory Gough, et al.
Published: (2011-01-01)

Protein Misfolding and Human Disease
by: Christopher Dobson
Published: (2002-01-01)

Alzheimer’s Type Neuropathological Changes in a Patient with Depression and Anxiety: A Case Report and Literature Review of Neuropathological Correlates of Neuropsychiatric Symptoms in Alzheimer’s Disease
by: Sumit Das
Published: (2023-01-01)

Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer’s disease model
by: Jiqing Xu, et al.
Published: (2016-08-01)

Retinal Levels of Amyloid Beta Correlate with Cerebral Levels of Amyloid Beta in Young APPswe/PS1dE9 Transgenic Mice before Onset of Alzheimer’s Disease
by: Xi Mei, et al.
Published: (2020-01-01)

Author Correction: Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer’s disease model
by: Jiqing Xu, et al.
Published: (2025-01-01)

Systematic review of amyloid-beta clearance proteins from the brain to the periphery: implications for Alzheimer’s disease diagnosis and therapeutic targets
by: Letian Huang, et al.
Published: (2025-12-01)

The Neuropathology of Autism
by: Gene J. Blatt
Published: (2012-01-01)

Iatrogenic cerebral amyloid angiopathy and Alzheimer's disease co‐pathology
by: Francisco Hernández‐Fernández, et al.
Published: (2025-01-01)

Amyloid-β and heart failure in Alzheimer’s disease: the new vistas
by: Hayder M. Al-Kuraishy, et al.
Published: (2025-02-01)

Neuropathology and Neurochemistry of Nonmotor Symptoms in Parkinson's Disease
by: Isidro Ferrer
Published: (2011-01-01)

Structural Analysis of Amylin and Amyloid β Peptide Signaling in Alzheimer’s Disease
by: Longsheng Xie, et al.
Published: (2025-01-01)

Microglial Lyzl4 Facilitates β‐Amyloid Clearance in Alzheimer's Disease
by: Jie Pan, et al.
Published: (2025-01-01)

Cerebrospinal Fluid BACE1 Activity and Brain Amyloid Load in Alzheimer's Disease
by: Timo Grimmer, et al.
Published: (2012-01-01)

Amyloid-Related Imaging Abnormalities in Anti-Amyloid Monoclonal Antibody Therapy for Alzheimer’s Disease: Expert Recommendation for Standard MRI Protocol
by: Jimin Kim, et al.
Published: (2025-01-01)

Anti-Amyloid Imaging Abnormality in the Era of Anti-Amyloid Beta Monoclonal Antibodies: Recent Updates for the Radiologist
by: So Yeong Jeong, et al.
Published: (2025-01-01)

Lipidopathy disrupts peripheral and central amyloid clearance in Alzheimer's disease: Where are our knowledge
by: Shahram Darabi, et al.
Published: (2025-06-01)

Transport of Alzheimer's associated amyloid-β catalyzed by P-glycoprotein.
by: James W McCormick, et al.
Published: (2021-01-01)

Amyloid-Beta Induced Changes in Vesicular Transport of BDNF in Hippocampal Neurons
by: Bianca Seifert, et al.
Published: (2016-01-01)

Post-COVID-19 Neuropathology and Perspectives of Protective Roles of Estrogens
by: Rodrigo Portes Ureshino, et al.
Published: (2025-01-01)

Early Delivery of Misfolded PrP from ER to Lysosomes by Autophagy
by: Constanza J. Cortes, et al.
Published: (2013-01-01)

Second-generation anti-amyloid monoclonal antibodies for Alzheimer’s disease: current landscape and future perspectives
by: Byeong-Hyeon Kim, et al.
Published: (2025-01-01)

Delta-opioid receptor signaling alleviates neuropathology and cognitive impairment in the mouse model of Alzheimer’s disease by regulating microglia homeostasis and inhibiting HMGB1 pathway
by: Yuan Xu, et al.
Published: (2025-02-01)

Aducanumab, a Novel Anti-Amyloid Monoclonal Antibody, for the Treatment of Alzheimer’s Disease: A Comprehensive Review
by: Hannah W Haddad, et al.
Published: (2022-01-01)

Aduhelm, a novel anti-amyloid monoclonal antibody, for the treatment of Alzheimer’s Disease: A comprehensive review
by: Hannah W. Haddad, et al.
Published: (2022-07-01)

Neuropathology-based approach reveals novel Alzheimer's Disease genes and highlights female-specific pathways and causal links to disrupted lipid metabolism: insights into a vicious cycle
by: Yin Jin, et al.
Published: (2025-01-01)

Alzheimer-mutant γ-secretase complexes stall amyloid β-peptide production
by: Parnian Arafi, et al.
Published: (2025-02-01)

Electroacupuncture Improves Clearance of Amyloid-β through the Glymphatic System in the SAMP8 Mouse Model of Alzheimer’s Disease
by: Pei-zhe Liang, et al.
Published: (2021-01-01)

Shattering the Amyloid Illusion: The Microbial Enigma of Alzheimer’s Disease Pathogenesis—From Gut Microbiota and Viruses to Brain Biofilms
by: Anna Onisiforou, et al.
Published: (2025-01-01)

How Could Static Telepathology Improve Diagnosis in Neuropathology?
by: Myriam Remmelinck, et al.
Published: (2000-01-01)

In silico study about β-amyloid’s role in Alzheimer’s disease and glaucoma and prediction of its interactions with glaucoma related proteins
by: Nancy Maurya
Published: (2023-08-01)

Co-Localized in Amyloid Plaques Cathepsin B as a Source of Peptide Analogs Potential Drug Candidates for Alzheimer’s Disease
by: Marilena K. Theodoropoulou, et al.
Published: (2024-12-01)

Cofactors facilitate bona fide prion misfolding in vitro but are not necessary for the infectivity of recombinant murine prions.
by: Miguel Ángel Pérez-Castro, et al.
Published: (2025-01-01)

Diabetic Neuropathy: A Clinical and Neuropathological Study of 107 Patients
by: David S. Younger
Published: (2010-01-01)

Inhibitory Effect of Curcumin-Cu(II) and Curcumin-Zn(II) Complexes on Amyloid-Beta Peptide Fibrillation
by: Rona Banerjee
Published: (2014-01-01)

Pharmacological enhancement of slow-wave activity at an early disease stage improves cognition and reduces amyloid pathology in a mouse model of Alzheimer’s disease
by: Sedef Kollarik, et al.
Published: (2025-01-01)

The proline-rich antimicrobial peptide Api137 disrupts large ribosomal subunit assembly and induces misfolding
by: Simon Malte Lauer, et al.
Published: (2025-01-01)

The Dysexecutive Syndrome Associated with Ischaemic Vascular Disease and Related Subcortical Neuropathology: A Boston Process Approach
by: Melissa Lamar, et al.
Published: (2010-01-01)